Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Bock

Showing results (121-130 of 202) with videos related to

Pageof 21
Sort By:
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Selective alpha-1a adrenergic receptor antagonists. Effects of pharmacophore regio- and stereochemistry on potency and selectivityM A Patane, R M DiPardo, R P Price, et al.
Journal of Medicinal Chemistry|January 1, 1989
Benzodiazepine gastrin and brain cholecystokinin receptor ligands: L-365,260M G Bock, R M DiPardo, B E Evans, et al.
Journal of Medicinal Chemistry|September 1, 1990
Receptor ligands which bind the oxytocin receptor with selectivity and high affinity. Chemical modification of a Streptomyces silvensis derived cyclic hexapeptideM G Bock, R M DiPardo, P D Williams, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1986
Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokininB E Evans, M G Bock, K E Rittle, et al.
Diabetes, Obesity & Metabolism|September 4, 2007
Insulin glulisine, insulin lispro and regular human insulin show comparable end-organ metabolic effects: an exploratory studyK Horvath, G Bock, W Regittnig, et al.
Life Sciences|January 1, 1992
Radioligand binding studies reveal marked species differences in the vasopressin V1 receptor of rat, rhesus and human tissuesD J Pettibone, M T Kishel, C J Woyden, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 12, 2010
Assessment of different techniques for subcutaneous glucose monitoring in Type 1 diabetic patients during 'real-life' glucose excursionsJ K Mader, H Weinhandl, G Köhler, et al.
Journal of Medicinal Chemistry|January 1, 1988
Cholecystokinin antagonists. Synthesis and biological evaluation of 4-substituted 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepinesM G Bock, R M DiPardo, B E Evans, et al.
Molecular Ecology|December 5, 2014
What we still don't know about invasion geneticsDan G Bock, Celine Caseys, Roger D Cousens, et al.
Biological Chemistry|February 25, 2006
Generation and characterization of a humanized bradykinin B1 receptor mouseJ Fred Hess, Richard Z Chen, Patricia Hey, et al.
Pageof 21

Showing results (121-130 of 202) with videos related to

Sort By:
Pageof 21
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Selective alpha-1a adrenergic receptor antagonists. Effects of pharmacophore regio- and stereochemistry on potency and selectivityM A Patane, R M DiPardo, R P Price, et al.
Journal of Medicinal Chemistry|January 1, 1989
Benzodiazepine gastrin and brain cholecystokinin receptor ligands: L-365,260M G Bock, R M DiPardo, B E Evans, et al.
Journal of Medicinal Chemistry|September 1, 1990
Receptor ligands which bind the oxytocin receptor with selectivity and high affinity. Chemical modification of a Streptomyces silvensis derived cyclic hexapeptideM G Bock, R M DiPardo, P D Williams, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1986
Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokininB E Evans, M G Bock, K E Rittle, et al.
Diabetes, Obesity & Metabolism|September 4, 2007
Insulin glulisine, insulin lispro and regular human insulin show comparable end-organ metabolic effects: an exploratory studyK Horvath, G Bock, W Regittnig, et al.
Life Sciences|January 1, 1992
Radioligand binding studies reveal marked species differences in the vasopressin V1 receptor of rat, rhesus and human tissuesD J Pettibone, M T Kishel, C J Woyden, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 12, 2010
Assessment of different techniques for subcutaneous glucose monitoring in Type 1 diabetic patients during 'real-life' glucose excursionsJ K Mader, H Weinhandl, G Köhler, et al.
Journal of Medicinal Chemistry|January 1, 1988
Cholecystokinin antagonists. Synthesis and biological evaluation of 4-substituted 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepinesM G Bock, R M DiPardo, B E Evans, et al.
Molecular Ecology|December 5, 2014
What we still don't know about invasion geneticsDan G Bock, Celine Caseys, Roger D Cousens, et al.
Biological Chemistry|February 25, 2006
Generation and characterization of a humanized bradykinin B1 receptor mouseJ Fred Hess, Richard Z Chen, Patricia Hey, et al.
Pageof 21